GL1X · GenesisL1 explorer

MolNFT v1 · #91811 · protein

Crystal structure of human anaplastic lymphoma kinase in complex with acyliminobenzimidazole inhibitor 2

4FOC · ALK tyrosine kinase receptor: “Crystal structure of human anaplastic lymphoma kinase in complex with acyliminobenzimidazole inhibitor 2”. X-ray diffraction, 1 ligand (0UU), 3 pockets (best druggability 0.58). MolNFT v1 #91811 on…

PDB
4FOC
Type
protein
Length
296 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
ALK tyrosine kinase receptor
EC
2.7.10.1
UniProt
Q9UM73
Ligands
0UU
Pockets
3 · best druggability 0.58

Structure

x-ray diffraction · 1 distinct chain · 42% helix, 17% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AALK tyrosine kinase receptor (EC 2.7.10.1)protein29642% helix, 17% strandQ9UM73

Ligands and binding sites

  • 0UU · methyl cis-4-[2-(benzoylamino)-6-(piperidin-1-ylmethyl)-1H-benzimidazol-1-yl]cyclohexanecarboxylate · ligand · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

3 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
12420.580.79300UU
2510.340.7814empty
3650.310.7413empty

Compared structures

  • 4FOC · Crystal structure of human anaplastic lymphoma kinase in complex with… · the same entry in another collection · chain A against A, TM-score 1.00
  • Q9UM73 · AlphaFold monomer V2.0 prediction for ALK tyrosine kinase receptor (Q9UM73) · a predicted model of the same protein · chain A against A, TM-score 0.98

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.